Trends in antipsychotic prescribing to children and adolescents in England: cohort study using 2000–19 primary care data

Gómez-Lumbreras, 2021, Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study, Psychopharmacology (Berl), 238, 1805, 10.1007/s00213-021-05809-8 Pringsheim, 2011, The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005–2009, J Child Adolesc Psychopharmacol, 21, 537, 10.1089/cap.2010.0145 Nakane, 2022, Trends in prescribing antipsychotics for children and adolescents in Japan: a descriptive epidemiological study using a large-scale pharmacy dataset, Child Psychiatry Hum Dev, 10.1007/s10578-022-01330-x Klau, 2022, Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018, Aust N Z J Psychiatry, 56, 1477, 10.1177/00048674211067720 Harrison, 2012, Antipsychotic medication prescribing trends in children and adolescents, J Pediatr Health Care, 26, 139, 10.1016/j.pedhc.2011.10.009 Libowitz, 2021, The burden of antipsychotic-induced weight gain and metabolic syndrome in children, Front Psychiatry, 12, 10.3389/fpsyt.2021.623681 Rani, 2008, Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom, Pediatrics, 121, 1002, 10.1542/peds.2007-2008 Kalverdijk, 2017, A multi-national comparison of antipsychotic drug use in children and adolescents, 2005–2012, Child Adolesc Psychiatry Ment Health, 11, 55, 10.1186/s13034-017-0192-1 Kaguelidou, 2020, Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study, Epidemiol Psychiatr Sci, 29, e117, 10.1017/S2045796020000293 Marston, 2014, Prescribing of antipsychotics in UK primary care: a cohort study, BMJ Open, 4, 10.1136/bmjopen-2014-006135 Bonnot, 2017, Influence of socioeconomic status on antipsychotic prescriptions among youth in France, BMC Psychiatry, 17, 82, 10.1186/s12888-017-1232-3 Verdoux, 2013, Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers, Encephale, 39, S22, 10.1016/j.encep.2012.10.009 Wolf, 2019, Data resource profile: Clinical Practice Research Datalink (CPRD) aurum, Int J Epidemiol, 48, 1740, 10.1093/ije/dyz034 2022 Brayfield, 2017 Radojčić, 2017, Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: a population-based cohort study, Neurotoxicol Teratol, 61, 58, 10.1016/j.ntt.2017.02.005 Russell, 2022, Time trends in autism diagnosis over 20 years: a UK population-based cohort study, J Child Psychol Psychiatry, 63, 674, 10.1111/jcpp.13505 D'Alò, 2021, Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis, Health Qual Life Outcomes, 19, 33, 10.1186/s12955-021-01669-0 Krause, 2018, Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: a network meta-analysis, Eur Neuropsychopharmacol, 28, 659, 10.1016/j.euroneuro.2018.03.008 Dinnissen, 2020, Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence, Eur Child Adolesc Psychiatry, 29, 1717, 10.1007/s00787-020-01488-6